
Redefining epilepsy monitoring
Epiminder introduces Minder®, the first FDA-authorised* implantable continuous EEG monitoring (iCEM™) system, designed for continuous monitoring of brain activity. This innovative solution empowers patients and healthcare professionals in the management of drug-resistant epilepsy.
Learn more about MinderIntroducing Minder
continuous EEG monitoring
Minder is transforming epilepsy care through continuous long-term EEG monitoring.
Extended monitoring window
Minder extends monitoring from days to months or years, capturing infrequent events that traditional EEGs miss.
Enhanced treatment planning
Potential to support drug-therapy monitoring and pre-surgical planning with continuous, objective data on EEG activity.
Life uninterrupted
Patients maintain normal daily activities while collecting critical brain activity data.
Remote care capabilities
Facilitates remote monitoring to aid the care of patients and regular clinical assessment.


Understanding the global impact of epilepsy
Epilepsy affects over 52 million people worldwide, with nearly 40% experiencing drug-resistant forms. The Minder system offers a revolutionary solution for continuous monitoring, empowering patients and healthcare providers alike.
52 million
people globally are affected by epilepsy
40%
experience drug-resistant forms of epilepsy
We have a commitment to improving the lives of those living with epilepsy
Integrity in patient care
We prioritise honesty and transparency in all our interactions with healthcare professionals and patients.
Innovation grounded in clinical evidence
Our solutions are developed based on rigorous scientific research and validation.
Empowerment through actionable data
We provide insights that allow physicians to help patients take control of their health.
Collaboration with the global epilepsy community
Together, we strive to advance epilepsy care and support.

Discover the future of epilepsy monitoring
Discover how Minder revolutionises epilepsy treatment in individuals with drug-resistant epilepsy through continuous monitoring.